Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”

Khalaf Kridin, Ralf J. Ludwig

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e169-e170
JournalJournal of the American Academy of Dermatology
Volume91
Issue number6
Early online date6 Aug 2024
DOIs
StatePublished - Dec 2024

Keywords

  • CTCL
  • atopic dermatitis
  • dupilumab
  • mycosis fungoides

Cite this